Document is current
Any future updates will be listed below
-
Authors
Heyland, Daren K.
van Zanten, Arthur R. H.
Grau-Carmona, Teodoro
Evans, David
Beishuizen, Albertus
Schouten, Jeroen
Hoiting, Oscar
Bordejé, Maria Luisa
Krell, Kenneth
Klein, David J.
Gonzalez, Jesus
Perez, Aitor
Brown, Randy
James, Joyce
Harris, M. Scott https://orcid.org/0000-0001-5141-5773
,
Heyland, Daren K.
Evans, David C.
Jolley, Sarah
Raines, Ronald
Krell, Kenneth
Falls, Idaho
Grau-Carmona, Teodoro
Serviá-Goixart, Lluis
Perez-Quesada, Sonia
Herrero-Meseguer, Jose Ignacio
Calvo-Herranz, Enrique
Lorencio, Carol
Peredes, Amparo
Yébenes-Reyes, Juan Carlos
Garcia-Martinez, Miguel Angel
Cervera, Manuel
Bordejé, Maria Luisa
Fernadez-Ortega, Juan Franscisco
Fernández-González, Inmaculada
van Zanten, Arthur
Beishuizen, Albertus
Schouten, Jeroen
Hoiting, Oscar
Wilhelmina, Canisius
Stelfox, Tom
Posadas, Juan
-
Funding
Funding for this research was provided by:
Lyric Pharmaceuticals
- License Information
-
More Information
Article History
Received: 12 December 2018
Accepted: 4 March 2019
First Online: 6 May 2019
Compliance with ethical standards
:
: Dr. Heyland served as a consultant to Lyric Pharmaceuticals in the design and execution of this trial. Dr. James, Dr. Harris and Mr. Brown were employees of Lyric Pharmaceuticals. Dr. Gonzalez and Mr. Perez were employees of Pivotal SL, the clinical research organization that conducted the trial on behalf of Lyric.
: The Institutional Review Boards (IRBs)/Independent Ethics Committees (ECs) approved the study protocol at all participating sites.
: The full trial protocol and trial data supporting this publication can be obtained by contacting the corresponding author.
